Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: A cross-sectional study

Biological Psychiatry

Volumn 72, Issue 9, 2012, Pages 744-751

  Hasan, Alkomiet ^a   Wobrock, Thomas ^a   Grefkes, Christian ^b   Labusga, Marcin ^a   Levold, Katrin ^a   Schneider Axmann, Thomas ^a   Falkai, Peter ^a   Müller, Hendrik ^b   Klosterkötter, Joachim ^b   Bechdolf, Andreas ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cortical inhibition; first episode schizophrenia; GABA; prodrome; schizophrenia; transcranial magnetic stimulation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRALATERAL SILENT PERIOD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEFICIENT INHIBITORY CORTICAL NETWORK; FACILITATION; FEMALE; HUMAN; INTRACORTICAL FACILITATION; LATENT PERIOD; MALE; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHIZOPHRENIA; SHORT LATENCY INTRACORTICAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; NEURAL INHIBITION; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84867086588     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.03.005     Document Type: Article

References (74)

1. K.E. Stephan, K.J. Friston, C.D. Frith Dysconnection in schizophrenia: From abnormal synaptic plasticity to failures of self-monitoring Schizophr Bull 35 2009 509 527
2. O.D. Howes, S. Kapur The dopamine hypothesis of schizophrenia: Version III - the final common pathway Schizophr Bull 35 2009 549 562
3. J.H. Krystall, B. Moghaddam Contributions of glutmate and GABA systems to the neurobiology and treatment of schizophrenia D.R. Weinberger, P.J. Harrison, Schizophrenia 2011 Wiley-Blackwell Chichester, UK 433 461
4. A. Schmitt, A. Hasan, O. Gruber, P. Falkai Schizophrenia as a disorder of disconnectivity Eur Arch Psychiatry Clin Neurosci 261 suppl 2 2011 150 154
5. S. Ruhrmann, F. Schultze-Lutter, R.K. Salokangas, M. Heinimaa, D. Linszen, P. Dingemans Prediction of psychosis in adolescents and young adults at high risk: Results from the prospective European prediction of psychosis study Arch Gen Psychiatry 67 2010 241 251
6. T.D. Cannon, K. Cadenhead, B. Cornblatt, S.W. Woods, J. Addington, E. Walker Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America Arch Gen Psychiatry 65 2008 28 37
7. P. Fusar-Poli, P. McGuire, S. Borgwardt Mapping prodromal psychosis: A critical review of neuroimaging studies Eur Psychiatry 27 2011 181 191
8. R. Smieskova, P. Fusar-Poli, P. Allen, K. Bendfeldt, R.D. Stieglitz, J. Drewe Neuroimaging predictors of transition to psychosis - a systematic review and meta-analysis Neurosci Biobehav Rev 34 2010 1207 1222
9. S.J. Borgwardt, A. Riecher-Rossler, P. Dazzan, X. Chitnis, J. Aston, M. Drewe Regional gray matter volume abnormalities in the at risk mental state Biol Psychiatry 61 2007 1148 1156
10. C. Pantelis, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, L.J. Phillips Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison Lancet 361 2003 281 288
11. A. Mechelli, A. Riecher-Rossler, E.M. Meisenzahl, S. Tognin, S.J. Wood, S.J. Borgwardt Neuroanatomical abnormalities that predate the onset of psychosis: A multicenter study Arch Gen Psychiatry 68 2011 489 495
12. S. Borgwardt, P. McGuire, P. Fusar-Poli Gray matters! Mapping the transition to psychosis Schizophr Res 133 2011 63 67
13. P. Fusar-Poli, J. Perez, M. Broome, S. Borgwardt, A. Placentino, E. Caverzasi Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis Neurosci Biobehav Rev 31 2007 465 484
14. P. Fusar-Poli, S. Borgwardt, A. Crescini, G. Deste, M.J. Kempton, S. Lawrie Neuroanatomy of vulnerability to psychosis: A voxel-based meta-analysis Neurosci Biobehav Rev 35 2011 1175 1185
15. A. Brockhaus-Dumke, F. Schultze-Lutter, R. Mueller, I. Tendolkar, A. Bechdolf, R. Pukrop Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients Biol Psychiatry 64 2008 376 384
16. M. Bodatsch, S. Ruhrmann, M. Wagner, R. Muller, F. Schultze-Lutter, I. Frommann Prediction of psychosis by mismatch negativity Biol Psychiatry 69 2011 959 966
17. S. Ozgurdal, Y. Gudlowski, H. Witthaus, W. Kawohl, I. Uhl, M. Hauser Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia Schizophr Res 105 2008 272 278
18. I. Frommann, J. Brinkmeyer, S. Ruhrmann, E. Hack, A. Brockhaus-Dumke, A. Bechdolf Auditory P300 in individuals clinically at risk for psychosis Int J Psychophysiol 70 2008 192 205
19. O. van der Stelt, J.A. Lieberman, A. Belger Auditory P300 in high-risk, recent-onset and chronic schizophrenia Schizophr Res 77 2005 309 320
20. F.M. Benes Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain Schizophr Bull 24 1998 219 230
21. F.M. Benes, B. Lim, D. Matzilevich, J.P. Walsh, S. Subburaju, M. Minns Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars Proc Natl Acad Sci U S A 104 2007 10164 10169
22. F.M. Benes Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders Neuropharmacology 60 2011 1232 1242
23. D.A. Lewis, T. Hashimoto, D.W. Volk Cortical inhibitory neurons and schizophrenia Nat Rev Neurosci 6 2005 312 324
24. T. Hashimoto, H.H. Bazmi, K. Mirnics, Q. Wu, A.R. Sampson, D.A. Lewis Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia Am J Psychiatry 165 2008 479 489
25. M. Beneyto, A. Abbott, T. Hashimoto, D.A. Lewis Lamina-specific alterations in cortical GABAA receptor subunit expression in schizophrenia Cereb Cortex 21 2011 999 1011
26. R.D. Paz, N.C. Andreasen, S.Z. Daoud, R. Conley, R. Roberts, J. Bustillo, N.I. Perrone-Bizzozero Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia Am J Psychiatry 163 2006 1829 1831
27. P. Eichhammer, R. Wiegand, A. Kharraz, B. Langguth, H. Binder, G. Hajak Cortical excitability in neuroleptic-naive first-episode schizophrenic patients Schizophr Res 67 2004 253 259
28. Z.J. Daskalakis, B.K. Christensen, R. Chen, P.B. Fitzgerald, R.B. Zipursky, S. Kapur Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation Arch Gen Psychiatry 59 2002 347 354
29. P.B. Fitzgerald, T.L. Brown, Z.J. Daskalakis, J. Kulkarni A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia Psychopharmacology (Berl) 162 2002 74 81
30. P.B. Fitzgerald, T.L. Brown, Z.J. Daskalakis, J. Kulkarni A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia Psychiatry Res 114 2002 11 22
31. S.K. Liu, P.B. Fitzgerald, M. Daigle, R. Chen, Z.J. Daskalakis The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia Biol Psychiatry 65 2009 503 509
32. T. Wobrock, M. Schneider, D. Kadovic, T. Schneider-Axmann, U.K. Ecker, W. Retz Reduced cortical inhibition in first-episode schizophrenia Schizophr Res 105 2008 252 261
33. T. Wobrock, T. Schneider-Axmann, W. Retz, M. Rosler, D. Kadovic, P. Falkai, M. Schneider Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation Pharmacopsychiatry 42 2009 194 201
34. E. Soubasi, E. Chroni, P. Gourzis, A. Zisis, S. Beratis, P. Papathanasopoulos Cortical motor neurophysiology of patients with schizophrenia: A study using transcranial magnetic stimulation Psychiatry Res 176 2010 132 136
35. U. Ziemann TMS and drugs Clin Neurophysiol 115 2004 1717 1729
36. A. Bechdolf, H. Muller, H. Stutzer, M. Wagner, W. Maier, M. Lautenschlager Rationale and baseline characteristics of PREVENT: A second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis Schizophr Bull 37 suppl 2 2011 S111 S121
37. R.C. Oldfield The assessment and analysis of handedness: The Edinburgh inventory Neuropsychologia 9 1971 97 113
38. S.R. Kay, A. Fiszbein, L.A. Opler The Positive and Negative Syndrome Scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
39. W.B.R. Guy CGI: Clinical Global Impressions 1976 National Institute of Mental Health Rockville, MD
40. J. Endicott, R.L. Spitzer, J.L. Fleiss, J. Cohen The Global Assessment Scale A procedure for measuring overall severity of psychiatric disturbance Arch Gen Psychiatry 33 1976 766 771
41. T.J. Miller, T.H. McGlashan, J.L. Rosen, L. Somjee, P.J. Markovich, K. Stein, S.W. Woods Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity Am J Psychiatry 159 2002 863 865
42. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 2004 American Psychiatric Association Washington, DC
43. S.W. Woods Chlorpromazine equivalent doses for the newer atypical antipsychotics J Clin Psychiatry 64 2003 663 667
44. A. Hasan, M.A. Nitsche, M. Herrmann, T. Schneider-Axmann, L. Marshall, O. Gruber Impaired long-term depression in schizophrenia: A cathodal tDCS pilot study [published online ahead of print September 5] Brain Stimul 2012
45. V. Di Lazzaro, A. Oliviero, P. Profice, E. Saturno, F. Pilato, A. Insola Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans Electroencephalogr Clin Neurophysiol 109 1998 397 401
46. T. Kujirai, M.D. Caramia, J.C. Rothwell, B.L. Day, P.D. Thompson, A. Ferbert Corticocortical inhibition in human motor cortex J Physiol 471 1993 501 519
47. Z.J. Daskalakis, B.K. Christensen, R. Chen, P.B. Fitzgerald, R.B. Zipursky, S. Kapur Effect of antipsychotics on cortical inhibition using transcranial magnetic stimulation Psychopharmacology (Berl) 170 2003 255 262
48. H.R. Siebner, J. Dressnandt, C. Auer, B. Conrad Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia Muscle Nerve 21 1998 1209 1212
49. M. Sommer, A. Alfaro, M. Rummel, S. Speck, N. Lang, T. Tings, W. Paulus Half sine, monophasic and biphasic transcranial magnetic stimulation of the human motor cortex Clin Neurophysiol 117 2006 838 844
50. M. Orth, J.C. Rothwell The cortical silent period: Intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse Clin Neurophysiol 115 2004 1076 1082
51. M.R. Broome, P. Matthiasson, P. Fusar-Poli, J.B. Woolley, L.C. Johns, P. Tabraham Neural correlates of movement generation in the 'at-risk mental state' Acta Psychiatr Scand 122 2010 295 301
52. M.C. Saka, E.C. Atbasoglu, H.D. Ozguven, H.O. Sener, E. Ozay Cortical inhibition in first-degree relatives of schizophrenic patients assessed with transcranial magnetic stimulation Int J Neuropsychopharmacol 8 2005 595 599
53. E.F. Walker Developmentally moderated expressions of the neuropathology underlying schizophrenia Schizophr Bull 20 1994 453 480
54. V. Di Lazzaro, F. Pilato, M. Dileone, F. Ranieri, V. Ricci, P. Profice GABAA receptor subtype specific enhancement of inhibition in human motor cortex J Physiol 575 2006 721 726
55. D. Volk, M. Austin, J. Pierri, A. Sampson, D. Lewis GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: Decreased expression in a subset of neurons Am J Psychiatry 158 2001 256 265
56. P. Fusar-Poli, J.M. Stone, M.R. Broome, I. Valli, A. Mechelli, M.A. McLean Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis Arch Gen Psychiatry 68 2011 881 890
57. S.M. Clinton, J.H. Meador-Woodruff Thalamic dysfunction in schizophrenia: Neurochemical, neuropathological, and in vivo imaging abnormalities Schizophr Res 69 2004 237 253
58. P. Fusar-Poli, O.D. Howes, P. Allen, M. Broome, I. Valli, M.C. Asselin Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis Mol Psychiatry 16 2011 67 75
59. P. Fusar-Poli, O.D. Howes, P. Allen, M. Broome, I. Valli, M.C. Asselin Abnormal frontostriatal interactions in people with prodromal signs of psychosis: A multimodal imaging study Arch Gen Psychiatry 67 2010 683 691
60. P.B. Fitzgerald, T.L. Brown, Z.J. Daskalakis, A. deCastella, J. Kulkarni A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation Schizophr Res 56 2002 199 209
61. M. Bajbouj, J. Gallinat, L. Niehaus, U.E. Lang, S. Roricht, B.U. Meyer Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia Pharmacopsychiatry 37 2004 74 80
62. B.K. Puri, N.J. Davey, P.H. Ellaway, S.W. Lewis An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex Br J Psychiatry 169 1996 690 695
63. Z.J. Daskalakis, B.K. Christensen, P.B. Fitzgerald, B. Moller, S.I. Fountain, R. Chen Increased cortical inhibition in persons with schizophrenia treated with clozapine J Psychopharmacol 22 2008 203 209
64. Y. Wu, M. Blichowski, Z.J. Daskalakis, Z. Wu, C.C. Liu, M.A. Cortez, O.C. Snead 3rd Evidence that clozapine directly interacts on the GABAB receptor Neuroreport 22 2011 637 641
65. B. Langguth, P. Eichhammer, C. Spranz, M. Landgrebe, U. Frick, P. Sand, G. Hajak Modulation of human motor cortex excitability by quetiapine Psychopharmacology (Berl) 196 2008 623 629
66. R. Chen Interactions between inhibitory and excitatory circuits in the human motor cortex Exp Brain Res 154 2004 1 10
67. T. Wobrock, A. Hasan, B. Malchow, C. Wolff-Menzler, B. Guse, N. Lang Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse Psychopharmacology (Berl) 208 2010 353 363
68. A. Hasan, M.A. Nitsche, B. Rein, T. Schneider-Axmann, B. Guse, O. Gruber Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation Behav Brain Res 224 2011 15 22
69. Z.J. Daskalakis, B.K. Christensen, P.B. Fitzgerald, R. Chen Dysfunctional neural plasticity in patients with schizophrenia Arch Gen Psychiatry 65 2008 378 385
70. M.V. Frantseva, P.B. Fitzgerald, R. Chen, B. Moller, M. Daigle, Z.J. Daskalakis Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning Cereb Cortex 18 2008 990 996
71. T. Oxley, P.B. Fitzgerald, T.L. Brown, A. de Castella, Z.J. Daskalakis, J. Kulkarni Repetitive transcranial magnetic stimulation reveals abnormal plastic response to premotor cortex stimulation in schizophrenia Biol Psychiatry 56 2004 628 633
72. T. Wobrock, A. Hasan, P. Falkai Innovative treatment approaches in schizophrenia enhancing neuroplasticity: Aerobic exercise, erythropoetin and repetitive transcranial magnetic stimulation [published online ahead of print January 26] Curr Pharm Biotechnol 2012
73. A. Aleman, I.E. Sommer, R.S. Kahn Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: A meta-analysis J Clin Psychiatry 68 2007 416 421
74. J.J. Dlabac-de Lange, R. Knegtering, A. Aleman Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: Review and meta-analysis J Clin Psychiatry 71 2010 411 418